Simultaneous double-culprit in-stent thrombosis. Who is the guilty prisoner behind bars: drug-eluting stent, bare-metal stent, or indication for treatment?

Fischman, 1994, A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators, N Engl J Med, 331, 496, 10.1056/NEJM199408253310802 Schofer, 2003, Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-bind, randomized controlled trial (E-SIRIUS), Lancet, 362, 1093, 10.1016/S0140-6736(03)14462-5 Greenberg, 2004, Can we afford to eliminate restenosis? Can we afford no to?, J Am Coll Cardiol, 43, 513, 10.1016/j.jacc.2003.11.020 Serruys, 1991, Angiographic follow-up after placement of a self expanding coronary artery stent, N Engl J Med, 324, 13, 10.1056/NEJM199101033240103 Moussa, 1997, Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors, and clinical outcome, J Am Coll Cardiol, 29, 6, 10.1016/S0735-1097(96)00452-4 Bertrand, 1998, Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: the Full Anticoagulation Versus Aspirin and Ticlopidine (FANTASTIC) study, Circulation, 98, 1507, 10.1161/01.CIR.98.16.1597 Cutlip, 2001, Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials, Circulation, 103, 1967, 10.1161/01.CIR.103.15.1967 Lee, 2005, Triple versus dual antiplatelet therapy after coronary stenting. Impact on stent thrombosis, J Am Coll Cardiol, 46, 1833, 10.1016/j.jacc.2005.07.048 Bavry, 2005, What is the risk of stent thrombosis associated with the use of paclitaxel drug eluting stents for percutaneous coronary interventions?, J Am Coll Cardiol, 45, 941, 10.1016/j.jacc.2004.11.064 Bolognese L. Attività dei laboratori di emodinamica italiani nel 2004. Il Giornale Italiano di Cardiologia Invasiva 2005; (Suppl 2), 3-7. American Heart Association, 2002 Gurbel, 2002, Could stent design affect platelet activation? Results of the Platelet Activation in STenting (PAST) study, J Invasive Cardiol, 14, 584 FDA public health web notification: information for physicians on subacute thrombosis (SAT) and hypersensitivity reactions with the use of the Cordis CYPHER coronary stent. US Food and Drug Administration, 2003. Silva, 1999, Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome, Am Heart J, 138, 446, 10.1016/S0002-8703(99)70146-8 Cheneau, 2003, Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study, Circulation, 108, 43, 10.1161/01.CIR.0000078636.71728.40 Uren, 2002, Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry, Eur Heart J, 23, 124, 10.1053/euhj.2001.2707 Farb, 2003, Pathological mechanisms of fatal late coronary stent thrombosis in humans, Circulation, 108, 1701, 10.1161/01.CIR.0000091115.05480.B0 Finn, 2005, Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents, Circulation, 112, 270, 10.1161/CIRCULATIONAHA.104.508937 Iakovou, 2005, Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents, JAMA, 293, 2126, 10.1001/jama.293.17.2126